history of CELLINBIO
Our patent technology transfer regarding our nano-drug delivery material
Arirang International Broadcasting.
Functional patent material Japanese trademark registration
Korean Skin Research Center (KSRC) Business Agreement
NICE Technical Evaluation Best Companies
Selection of Best Practices for National Policy Development of Pine Leaf Juice Powder (Ministry of Agriculture, Forestry and Fisheries)
Bundang Seoul National University Hospital Signing Business Agreement
Registered an American patent for our new biological drug candidate, CIB1401H Peptide.
Registered an American patent for our new biological drug candidate, CIB1401H Peptide.
Launch of export of functional bio materials to China
Launched our cosmeceutical skincare brand, CELLIN-BioLab.
Registered a patent for our new biological drug candidate, CIB1401H.
Selected as a high value-added food technology development project(Ministry for Food, Agriculture, Forestry and Fisheries).
Had a patent technology transfer for our antibacterial peptide, Lactophorin.
Selected as a core industrial technology development project(Ministry of Trade, Industry and Energy).
Material patent registration for net system
Prolipil-F4 Material Patent Registration
Patent registration for electrospinning compositions
Registered a patent for our Proliphil-C3 substance.
Selected as a government-linked pre-cycle new drug development project(Korea Drug Development Fund).
Received the Excellent R&D Corporation Medal from Gyeonggi Province.
Certified as a technological innovation-type SME by INNO-BIZ(INNO-BIZ).
Launch of export of functional bio materials to Japan
Designation of K-OTC and commencement of trading (Financial Investment Association)
Selected as a business of industrial growth to lead the metropolitan economic zone(Ministry of Knowledge Economy).
Registered a patent for our VITA-HA.
Selected as a business for special cases on military service(Military Manpower Administration).
Selected as a convergence technology development company(Ministry of SMEs and Startups).
xpanded and moved its biomaterial research institute.
of SMEs and Startups). Expanded and moved its biomaterial research institute. Selected as an excellent case among national projects to develop a process for ADSC-CM stem cell culture(Ministry of SMEs and Startups).
CIB001 (KCTC11717BP) Patent Strain Deposit
Completion of biological material production quasi-GMP facility
Produced our lactobacillus ingredient, CIB 001.
Obtained an approval as a venture firm(Korea Technology Finance Corporation).
Obtained permission for our annex research institute, "Biomaterial Research Institute"(Korea Industrial Technology Association).
Launched a cosmeceutical brand "The-CELLIN."
Founded CELLINBIO Co., Ltd. and opened an R&D office.